According to the PTSD United, 70% of adults in the United States experience some type of traumatic event in their lives. Of those, 20 will go on to develop Post-Traumatic Stress Disorder (PTSD). That comes out to roughly 44.7 million people in the US suffering from PTSD. Unfortunately, a great many of these cases have proven treatment-resistant, even after multiple attempts and several different antidepressants.
Ketamine is an exciting new avenue for those seeking treatment. It provides a relief from symptoms of depression that can be felt within hours, unlike standard antidepressant medications that can take four-to-six weeks to take hold.